Table 2 Patient characteristics. HCC: hepatocellular carcinoma; CCC: cholangiocellular carcinoma
| Â | HCC | CCC | All tumors |
|---|---|---|---|
Total no. | 71 | 27 | 98 |
Sex | |||
 male | 57 | 23 | 80 |
 female | 14 | 4 | 18 |
Age (years) | Â | Â | Â |
 mean | 63.9 | 65.5 | 64.4 |
 median | 65.0 | 66.0 | 65 |
Survival (months) | Â | Â | Â |
 mean | 20.3 | 14.7 | 18.8 |
 median | 18.0 | 11.0 | 15.0 |
Stage (n) | |||
 I | 24 [34%] | 8 [30%] | 32 [33%] |
 II | 20 [28%] | 13 [48%] | 33 [34%] |
 IIIA | 18 [26%] | 1 [4%] | 19 [19%] |
 IIIB | 0 [0%] | 0 [0%] | 0 [0%] |
 IIIC | 1 [1%] | 0 [0%] | 1 [1%] |
 IVA | 0 [0%] | 3 [11%] | 3 [3%] |
 IVB | 8 [11%] | 2 [7%] | 10 [10%] |
Grading (n) | |||
 G1 | 13 [18%] | 1 [4%] | 14 [14%] |
 G2 | 43 [61%] | 18 [66%] | 61 [62%] |
 G3 | 15 [21%] | 7 [26%] | 22 [23%] |
 G4 | 0 [0%] | 1 [4%] | 1 [1%] |